[ad_1]
The purchase of these vaccines was still being considered by the outgoing Cabinet in November, but, as the Health Ministry noted on Wednesday, “due to a possible technical error” in the Government’s Protocol, it was not available at that time.
It is established that the purchase of vaccine doses is approved according to the established proportions, that is, according to the so-called pro-rata principle. The specific number of vaccines was also not specified.
“Yesterday we received a request from the European Commission to confirm the final amount, whether Lithuania will continue to follow the pro-rata principle and reserve those 1.4 million. Amount. We propose not to change anything, to follow the pro-rata principle, only this time to leave it evidence in the minutes, ”said Health Minister Arūnas Dulkys at the meeting.
Lithuania has decided to buy vaccines from six companies: Moderna, AstraZeneca, Janssen Pharmaceutica NV, Sanofi and GSK, BioNTech and Pfizer and CureVac. In total, it is currently planned to buy about 7.8 million. dose.
Several thousand doses of the first vaccine from the European Union, BioNTech and Pfizer, arrived in Lithuania and other countries at Christmas, being the first to be vaccinated.
[ad_2]
